Home / News / India News / Article /
Bharat Biotech seeks DCGI's nod to extend shelf life of Covaxin
Updated On: 26 April, 2021 08:37 AM IST | New Delhi | PTI
Covaxin, along with Covishield manufactured by Serum Institute of India, are the two vaccines so far being used in India`s current COVID-19 vaccination drive. Russian vaccine Sputnik-V has also been approved for emergency use in India
Listen to this article :
Photo for representational purpose
Bharat Biotech has written to the India`s drug regulator seeking extension of the shelf-life of its indigenously developed COVID-19 vaccine Covaxin from six to 24 months, sources said on Sunday.
Covaxin, along with Covishield manufactured by Serum Institute of India, are the two vaccines so far being used in India`s current COVID-19 vaccination drive. Russian vaccine Sputnik-V has also been approved for emergency use in India.
Read Next Story
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT